Loading provider…
Loading provider…
Pulmonary Disease Physician in Chapel Hill, NC
NPI: 1225115785Primary Practice Location
UNC HOSPITALS
101 Manning Dr, Chapel Hill, NC
Primary Employer
UNC Faculty Physicians
uncmedicalcenter.org
HQ Phone
Get MD Scott's Phone Numberphone_androidMobile
Get MD Scott's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 94729Measurement of lung diffusing capacity | 22 | 22 |
| 2 | 94375Test to measure rate of airflow | 21 | 21 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 19 | 32 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 17 | 17 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 17 | 24 |
Critical Care of the Adult Patient With Cystic Fibrosis.
Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.
Authors: Margaret Leigh, Ashley Henderson
Publication Date: 2014-06-04
Authors: John Clancy, Scott Sagel, Drucy Borowitz
Journal: Ann Am Thorac Soc
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebos, DRUG: CB-280
Lead Sponsor: AstraZeneca
Collaborators: Parexel
Intervention / Treatment: DRUG: Placebo, DRUG: AZD5634
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Placebo, DRUG: ABBV-119, DRUG: ABBV-576, DRUG: Galicaftor, DRUG: Navocaftor